Lilly’s Foundayo shows cardiovascular safety in diabetes trial

Progress earnings beat by $0.17, revenue fell short of estimates

Investing.com · News 16m ago

Tech CEOs questioned Anthropic leader over AI safety warnings, WSJ reports

Investing.com · News 17m ago

Tech CEOs questioned Anthropic leader over AI safety warnings, WSJ reports

Investing.com · Investing_news 17m ago

Earnings call transcript: Progress Software beats Q3 2026 EPS, shares slip after hours

Investing.com · News 17m ago

Robinhood at Hood Summit ’26: pushing 24/7 trading

Investing.com · News 18m ago

Fed's Kashkari says inflation is 'still too high' even after softer-than-expected PCE data

CNBC · Economy 19m ago

ShinyHunters website goes offline after FBI deadline expires

Investing.com · News 19m ago

Neptune Insurance appoints David Noble to board

Investing.com · News 19m ago

Micron Q4 2026 slides: record $54B revenue, tight supply outlook

Investing.com · News 19m ago

Yext To Acquire Flamel.ai For Undisclosed Sum

NASDAQ · Markets 20m ago